These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12868004

  • 1. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans.
    Tang J, Mohr S, Du YD, Kern TS.
    Curr Eye Res; 2003 Jul; 27(1):7-13. PubMed ID: 12868004
    [Abstract] [Full Text] [Related]

  • 2. [The changes of histology and biochemical parameters in retina of the patient with diabetic retinopathy].
    Tang J, An XL, Song HG, Bing H.
    Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):689-91. PubMed ID: 16200860
    [Abstract] [Full Text] [Related]

  • 3. Vascular lesions in diabetes are distributed non-uniformly within the retina.
    Kern TS, Engerman RL.
    Exp Eye Res; 1995 May; 60(5):545-9. PubMed ID: 7615020
    [Abstract] [Full Text] [Related]

  • 4. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.
    Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Kern TS, Ball S, Berkowitz BA.
    Diabetologia; 2007 Sep; 50(9):1987-1996. PubMed ID: 17583794
    [Abstract] [Full Text] [Related]

  • 5. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia.
    Kern TS, Engerman RL.
    Arch Ophthalmol; 1996 Mar; 114(3):306-10. PubMed ID: 8600891
    [Abstract] [Full Text] [Related]

  • 6. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
    Kim D, Mecham RP, Nguyen NH, Roy S.
    Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
    [Abstract] [Full Text] [Related]

  • 7. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels.
    Badr GA, Tang J, Ismail-Beigi F, Kern TS.
    Diabetes; 2000 Jun; 49(6):1016-21. PubMed ID: 10866055
    [Abstract] [Full Text] [Related]

  • 8. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP.
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine.
    Du Y, Smith MA, Miller CM, Kern TS.
    J Neurochem; 2002 Mar; 80(5):771-9. PubMed ID: 11948240
    [Abstract] [Full Text] [Related]

  • 12. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice.
    Steinle JJ, Kern TS, Thomas SA, McFadyen-Ketchum LS, Smith CP.
    Exp Eye Res; 2009 Jun; 88(6):1014-9. PubMed ID: 19176214
    [Abstract] [Full Text] [Related]

  • 13. Captopril inhibits glucose accumulation in retinal cells in diabetes.
    Zhang JZ, Gao L, Widness M, Xi X, Kern TS.
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):4001-5. PubMed ID: 12939321
    [Abstract] [Full Text] [Related]

  • 14. A mouse model of diabetic retinopathy.
    Kern TS, Engerman RL.
    Arch Ophthalmol; 1996 Aug; 114(8):986-90. PubMed ID: 8694735
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.
    Fernandes R, Carvalho AL, Kumagai A, Seica R, Hosoya K, Terasaki T, Murta J, Pereira P, Faro C.
    Mol Vis; 2004 Aug 30; 10():618-28. PubMed ID: 15359219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability.
    Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC.
    Nitric Oxide; 2000 Dec 30; 4(6):590-6. PubMed ID: 11139367
    [Abstract] [Full Text] [Related]

  • 18. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro.
    Podestà F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C, Lorenzi M.
    Am J Pathol; 2000 Mar 30; 156(3):1025-32. PubMed ID: 10702418
    [Abstract] [Full Text] [Related]

  • 19. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
    Holoman NC, Aiello JJ, Trobenter TD, Tarchick MJ, Kozlowski MR, Makowski ER, De Vivo DC, Singh C, Sears JE, Samuels IS.
    J Neurosci; 2021 Apr 07; 41(14):3275-3299. PubMed ID: 33622781
    [Abstract] [Full Text] [Related]

  • 20. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye.
    Kumagai AK, Glasgow BJ, Pardridge WM.
    Invest Ophthalmol Vis Sci; 1994 May 07; 35(6):2887-94. PubMed ID: 8188484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.